He describes how Disc applied for and was awarded a CNPV for Bitopertin, which treats a rare disease that causes extreme sensitivity to sunlight. Plus, quickly ramping up a commercial team, and discussing Disc's two other development programs.

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comCurranz Supplement: Use code MIKKIPEDIA to get 20% off your first order - go to www.curranz.co.nz  or www.curranz.co.uk to order yours This week on the podcast Mikki speaks to Dr CAtherine Crofts in part 2 of their discussion on health about challenging the status quo in nutrition science. Together they take a critical look at the flaws in current dietary guidelines,

What if you could learn the secrets behind one of psychiatry's most significant breakthroughs in decades? In this episode of Power to the Patients, host Brandon Li sits down with Steve Brannan, Chief Medical Officer of Karuna Therapeutics, to explore the art of clinical trial excellence, the future of precision psychiatry, and the untold story behind developing the first new-mechanism schizophrenia drug in decades. Whether you're a researcher, clinician, or industry professional, this conversation

In this episode, Joe Moore talks with Megan Portnoy, a doctoral candidate in clinical psychology at Antioch University New England, about how ontological design can reshape the environments used in psychedelic-assisted therapy. Megan explains how physical space is not just a backdrop but an active participant in the therapeutic process, influencing emotion, cognition, and healing. She recently won an award for her presentation on this topic at PsychedelX. They explore how design principles that

Ardra Shephard, a musician, author, fashion-show TV host, podcaster, and MS advocate, discusses her experiences living with MS, including how she uses her story to educate and encourage others living with MS. She is joined by Jiwon Oh, MD, Medical Director of the Barlo Multiple Sclerosis Program at St. Michael’s Hospital, Toronto, ON, who describes how advancements in the diagnosis and treatment of MS have improved outcomes for individuals living with this condition.

Lisa Volenec, a patient advocate and General Manager of KMTV, Omaha, NE, shares how incorporating lifestyle modifications—such as diet, exercise, and community engagement—has enhanced her Parkinson disease treatment. She is joined by double-board-certified neurology and lifestyle medicine physician and fellowship-trained movement disorder specialist Rachel Dolhun, MD, DipABLM, principal medical advisor at The Michael J. Fox Foundation, who offers expert insights on integrating these strategies into

Dagny Zhu, MD, joins Neda Nikpoor, MD, for a discussion on how a refractive surgeon can build an authentic, patient-facing brand on social media. They cover what actually drives consults—relatable education, selective personal storytelling, and platform fit—plus how to address anti-LASIK noise with evidence, handle trolls without grandstanding, and keep a sustainable cadence you’ll stick to.

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, spoke with R. Nolan Townsend, MBA, CEO of Lexeo Therapeutics, a company developing gene therapies for cardiovascular diseases as well as CNS disorders including Alzheimer’s disease.Lexeo recently announced a partnership to advance cardiac RNA therapeutics as well as $80 million in equity financing. Mr. Townsend has been CEO of Lexeo Therapeutics since 2020. He previously held

️ Episode 176: FAHD1 and the Pyruvate-Driven Evolution of Hepatocellular Carcinoma In this episode of PaperCast Base by Base, we explore how multi-omics integration—spanning single-cell transcriptomics, spatial mapping, and causal genetic inference—uncovers a pyruvate-hyperactive epithelial subpopulation in hepatocellular carcinoma and identifies FAHD1 as a central regulator linked to poor prognosis and immune evasion. Study Highlights:The authors

In today’s Pharmaceutical Executive Daily, we cover market reaction to Novo Nordisk’s recent board shake-up, MJH Life Sciences’ acquisition of BPD Healthcare to strengthen its health system reach, and why clinical trial site satisfaction is becoming a key competitive differentiator for sponsors and CROs.

Pedja Filipović i Tanja Luković

What defines a psychopath? Are they born with these traits, or is it shaped by their environment? This episode delves into common characteristics of psychopathic personalities and examines the neurological basis for their actions. Discover why they exude charm, why keeping a steady head while talking signals a trait, and why many psychopaths achieve success. Key Moments: 00:00 Intro 00:30 Episode Overview 02:12 Superficial Charm 02:49 Need for Stimulation 03:12 Pathological Lying 03:35

This week, we’re throwing it back to when Jim connected with Sydney Robinson, CEO and co-founder of Vessl Prosthetics, based in London, Ontario. Sydney and her team are pioneering next-generation prosthetic solutions specifically designed for below-knee amputees. Their innovative technology features automatic adjustments that ensure a consistently comfortable fit—greatly improving quality of life for many.In 2025, Vessl Prosthetics made significant strides, securing key funding and

Pushing biologics beyond 200 mg/mL isn’t just a formulation challenge - it’s a delivery, manufacturing, and regulatory challenge too. Aggregation, precipitation, and sky-high viscosity make scaling these therapies a gauntlet for drug developers.In this episode of Life Science Solutions, host Chris Adkins continues the conversation on hyper-concentrated biologics with Ryan Doxey, VP of Tech Ops & CMC at Kymanox, and Nick Letourneau, PhD, Associate Director of Product Development &

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, President, at Pharma & Biopharma Outsourcing Association (PBOA).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gil, covering: How planned FDA budget cuts and the ongoing US government shutdown are impacting the industry. And the potential outlook if those issues remain unresolved... Why positive early-phase clinical trial

What is the difference between forward and reverse cardio-oncology? In our latest episode, Deputy Editor Dr. Carol Ann Remme (University of Amsterdam) interviews Dr. Rudolf de Boer (Erasmus Medical Center) about the new Review article by Meijers et al. Forward cardio-oncology focuses on cardiotoxicity and cardiac damage due to anti-cancer therapies in patients with prevalent cancer. In contrast, reverse cardio-oncology describes the phenomenon that cancer is more often discovered in patients with

I get a lot of questions from students and early-career professionals about what different industry roles actually mean: what does a Quality Engineer do? What’s Regulatory Affairs? How does R&D fit in?In this video, I walk through eight of the most common roles you’ll find in pharma, medtech, biotech, and diagnostics companies. We’ll talk about what each team does, how they connect, and how to think about which one might fit your strengths and interests.If you’re trying to figure out where you

This week, we welcome Jennifer Lentini, whose transplant journey began when she was just a teenager. On July 6, 1996, Jennifer received a life-saving heart transplant that gave her a second chance at life. But her story is far from over.Today, at age 42, Jennifer continues her fight. She joined us for this episode while on dialysis, awaiting a kidney transplant—and facing the reality that she may also need a second heart transplant. Jennifer’s story is one of

In this classic episode of Stuff to Blow Your Mind, Robert and Joe explore a host of scary, train-related topics, from the Victorian “railway madness” panic to ghost trains and more. (originally published 10/1/2024)See omnystudio.com/listener for privacy information.

Around 6,000 years ago, the Sahara was a lush grassland. Then, as if a switch flipped, it began to dry out, becoming the desert that we know today. Tipping points are moments in Earth’s history where gradual change suddenly becomes rapid and forms a new equilibrium.They’re one of the most alarming threats of our planet’s near future — and one of the most uncertain.When will a tipping point occur? Mathematicians are attempting to turn vague, apocalyptic visions into something that we can